The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rayaldee 30 microgram prolonged-release capsules, soft

Vifor Fresenius Medical Care Renal Pharma FrancePA22774/001/001

Main Information

Trade NameRayaldee 30 microgram prolonged-release capsules, soft
Active SubstancesCalcifediol
Dosage FormProlonged-release capsule, soft
Licence HolderVifor Fresenius Medical Care Renal Pharma France
Licence NumberPA22774/001/001

Group Information

ATC CodeA11CC06 calcifediol
H05BX Other anti-parathyroid agents


License statusWithdrawn
Withdrawn Date15/11/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back